The EU's Corporate Sustainability Reporting Directive (CSRD), which came into force at the beginning of 2023, aims to implement ESG (Environmental, Social, and Governance) as an elementary component of annual corporate reporting. For the Life Sciences industry, the implementation of the directive brings a number of requirements and necessary adjustments.
In "Navigating CSRD Reporting in Life Sciences", our experts explain the content of the CSRD and its implications for companies in the Life Sciences industry. It shows how the CSRD acts as a catalyst for the transformation to purpose-oriented, sustainable companies.
The relevant topics and challenges of the industry regarding the three ESG areas of environmental, social and governance are described in detail. ESG representatives of Bayer, Merck, and UCB have their say. Finally, six key recommendations for action are proposed.
